Donald Marvin - Mar 16, 2022 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role: Executive VP, CFO & COO
Signature: /s/ Matthew Rudolph, Attorney-in-Fact for Donald Marvin.
Stock symbol: CMMB
Transactions as of: Mar 16, 2022
Transactions value $: $1,638
Form type: 4
Date filed: 6/21/2022, 06:01 AM
Previous filing: Mar 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMMB	American Depositary Shares	Purchase	$825	+250	+16.67%	$3.30	1.75K	Mar 16, 2022	Direct	F1
transaction	CMMB	American Depositary Shares	Purchase	$813	+250	+14.29%	$3.25	2K	Mar 16, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMMB	Option to Purchase American Depositary Shares	Award	$0	+197K		$0.00	197K	Nov 8, 2021	American Depositary Shares	197K	$9.77	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2	No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3	The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.